Healthcare Sales & Marketing Network News: Biogen

Searching News Database: Biogen

HSMN NewsFeed - 17 Jul 2024
Alltrna Announces Updates to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2024
REGENXBIO Announces Leadership Transition
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2024
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
Regenerative Medicine Ophthalmology Personnel

HSMN NewsFeed - 29 May 2023
Abiogen Pharma Completes the Acquisition of Effrx
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jul 2022
Nuvalent Announces Leadership Promotions
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Mar 2022
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2022
Lyra Therapeutics Appoints Jim Tobin to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Nov 2021
Geneoscopy Closes $105M in Financing to Advance its Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention
Diagnostics Venture Capital

HSMN NewsFeed - 16 Sep 2021
Sutro Biopharma Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Aug 2021
KalGene Pharmaceuticals Inc. an Alzheimer's focused company using a next generation engineered drug candidate, has appointed new leadership
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 12 Jul 2021
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 May 2021
LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments
Biopharmaceutical Personnel

HSMN NewsFeed - 5 Apr 2021
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Dec 2020
Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of Niemann Pick Disease Types A and B With PLX-300
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Aug 2020
Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera(R)
Biopharmaceuticals Generics Neurology Product Launch

HSMN NewsFeed - 27 May 2020
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 19 May 2020
AllianceRx Walgreens Prime One of Only Two Specialty Pharmacies to Distribute Vyepti(TM), the First and Only Intravenous Preventive Treatment for Migraine
Biopharmaceuticals Distribution

HSMN NewsFeed - 5 May 2020
Ichnos Sciences Appoints David Lubner To Board Of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2020
Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jan 2020
Theragnostics Expands Team with Significant Appointments
Biopharmaceuticals Oncology Radiology Personnel

HSMN NewsFeed - 18 Dec 2019
Encoded Therapeutics Strengthens Senior Leadership Team with Key Appointments in Regulatory and Human Resources Functions
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 23 Sep 2019
FogPharma Expands Leadership Team with Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2019
Encoded Therapeutics Expands Leadership Team with Key Appointments, Adding Expertise in Manufacturing and Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2019
Geron Enhances Oncology Expertise to Advance Corporate Objectives
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Jul 2019
Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
Biopharmaceuticals Licensing

HSMN NewsFeed - 3 Jun 2019
Castle Creek Pharmaceuticals Appoints Mary Spellman, M.D., as Chief Medical Officer and Senior Vice President of Research & Development
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 8 Apr 2019
F2G Appoints Dr. Patrick Vink as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Apr 2019
Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2019
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jan 2019
ViaCyte Announces New Board Members
Regenerative Medicine Personnel

HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Oct 2018
EpiVax Oncology Appoints Dominique Bridon as Chief Technology Officer and Dan Adams to the Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Oct 2018
Adam Hacker, PhD Joins Autolus as Senior Vice President for Regulatory Affairs and Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Sep 2018
ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Aug 2018
Sobi(TM) Appoints Anne Marie de Jonge Schuermans as Head of Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Aug 2018
ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Jul 2018
Torque Appoints James Mullen as Chairman of Board of Directors, Maykin Ho, PhD, as Strategic Advisor to the Board of Directors, and Mario Sznol, MD, to Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Jul 2018
BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 Jul 2018
New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI(TM) (inotersen) for the Treatment of Hereditary ATTR Amyloidosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Jun 2018
BrainStorm Strengthens Executive Management Team with the Appointment of Susan Ward, Ph.D. and Joseph Petroziello
Regenerative Medicine Personnel

HSMN NewsFeed - 18 Jun 2018
Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2018
Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Apr 2018
AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Samsung Bioepis
Biopharmaceuticals Litigation Licensing

HSMN NewsFeed - 15 Mar 2018
Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Mar 2018
Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Jan 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 23 Jan 2018
Disarm Therapeutics Appoints Thomas Engber as Senior Vice President, Head of Neuropharmacology and Translational Sciences
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 11 Dec 2017
Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Nov 2017
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Nov 2017
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Nov 2017
Ionis Announces Management Transitions
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Oct 2017
Menlo Therapeutics Expands its Management Team
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 8 Sep 2017
Eloxx Pharmaceuticals Expands Management Team to Support Rapid Development of Lead Drug Candidate ELX-02 for the Treatment of Rare Genetic Diseases
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Aug 2017
Rhythm Expands Executive Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Aug 2017
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 31 Jul 2017
Foresee Pharmaceuticals Announces CEO Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 1 Jun 2017
SPINRAZA(R) (nusinersen) Approved in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 May 2017
Homology Medicines Strengthens Manufacturing and Product Development Expertise with Appointment of Tim Kelly as Senior Vice President, Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2017
Swedish Orphan Biovitrum AB - Elocta(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 May 2017
Ionis Pharmaceuticals Announces Phase 3 NEURO-TTR Study of Inotersen (IONIS-TTR Rx) Meets Both Primary Endpoints
Biopharmaceuticals

HSMN NewsFeed - 21 Mar 2017
Eyevensys Appoints Leading Life Sciences Executive and Ophthalmology Expert Dr. Garth Cumberlidge as Chairman
Biopharmaceuticals Devices Ophthalmology Personnel

HSMN NewsFeed - 9 Mar 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round
Biopharmaceuticals Oncology Personnel Venture Capital

HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Dec 2016
Biogen Names Michel Vounatsos Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2016
Grünenthal Receives Breakthrough Therapy Designation From U.S. FDA for Neridronic Acid for the Treatment of CRPS
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Dec 2016
Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA(TM) (Daclizumab Beta) for Multiple Sclerosis
Biopharmaceuticals Nerurology Regulatory

HSMN NewsFeed - 17 Nov 2016
FDA Grants Fast Track Designation for Development of E2609, Eisai's BACE Inhibitor for Early Alzheimer's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 Sep 2016
Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Aug 2016
BioLineRx Names Philip A. Serlin as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jul 2016
Genentech Provides Update on Phase III Study of Gazyva(R) in People With Previously Untreated Diffuse Large B-Cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Jul 2016
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 20 Jun 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jun 2016
Allecra Therapeutics Announces €22 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 May 2016
FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 May 2016
The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2016
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 30 Mar 2016
Biogen Appoints Michel Vounatsos Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2016
Curis Announces Expansion of Executive Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Feb 2016
Global Blood Therapeutics Announces Changes to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Feb 2016
Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jan 2016
Amylyx Announces Election of Nobel Laureate Walter Gilbert, PhD, to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 19 Jan 2016
Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 19 Jan 2016
Acorda to Acquire Biotie Therapies
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 17 Jan 2016
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Jan 2016
Alector Announces Closing of Series D Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 6 Jan 2016
Vernalis Announces Corvus Pharmaceuticals, Inc. as Its Worldwide Licensee for Their Adenosine Antagonist Program
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Jan 2016
Editas Medicine Expands Leadership Team with Key Organizational Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2016
Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 7 Dec 2015
Ignyta Appoints William Mccarthy as Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Dec 2015
Samsung Bioepis' RENFLEXIS(R) Infliximab Biosimilar Receives Regulatory Approval in Korea
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Dec 2015
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Nov 2015
Sobi and Biogen’s ELOCTA(R) (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 10 Nov 2015
Hi-Tech Pharmaceuticals Files Lawsuit Against IronMag Labs and Robert Dimaggio Over Racketeer Influenced and Corrupt Organizations (RICO) and Patent Infringement
Biopharmaceuticals Litigation

HSMN NewsFeed - 3 Nov 2015
Solid GT Raises $42.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Nov 2015
Castle Biosciences Announces the Appointment of Federico Monzon, M.D., FCAP as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 9 Oct 2015
Biogen Announces Departure of Tony Kingsley
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2015
Zafgen Announces Transition of Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 11 Sep 2015
Akebia Therapeutics Announces Additions to its Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2015
Amicus Therapeutics Strengthens Executive Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2015
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 May 2015
Autonomic Technologies Raises USD 38M in a Transatlantic Series D Financing
Devices Neurology Venture Capital Personnel

HSMN NewsFeed - 27 Apr 2015
Amicus Therapeutics Appoints David Allsop as Senior Vice President, International
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2015
VBL Therapeutics Reports Interim Topline Results From Phase 2 Clinical Trial of VB-111 in Recurrent Glioblastoma (rGBM)
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Mar 2015
Biogen Idec Becomes Biogen
Biopharmaceuticals

HSMN NewsFeed - 16 Mar 2015
Chiasma Announces Mark Leuchtenberger as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Feb 2015
PerkinElmer Elects Sylvie Grégoire to its Board of Directors
Devices Personnel

HSMN NewsFeed - 4 Feb 2015
Genentech’s Phase III Study of Gazyva(R) Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Jan 2015
Euclises Announces Appointment of Bobby Sandage as New CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Jan 2015
Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Jan 2015
Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Oct 2014
bioTheranostics Appoints Nicolas Barthelemy as President and CEO
Diagnostics Oncology Personnel

HSMN NewsFeed - 18 Sep 2014
Trevena Appoints Adam M. Koppel to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2014
BIND Therapeutics Appoints Two New Board Members
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Aug 2014
Health Canada Approves Eloctate(TM), the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Aug 2014
Akebia Therapeutics Announces Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2014
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jun 2014
Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2014
Regulus Appoints Paul C. Grint, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2014
Organizational Changes Strengthen and Expand Celgene Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2014
Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution

HSMN NewsFeed - 9 Apr 2014
Brainsway's Deep TMS System Will be Exclusively Marketed by Medison Pharma in Israel
Devices Neurology Distribution

HSMN NewsFeed - 7 Apr 2014
EndoBarrier(R) Therapy Receives Reimbursement Coverage in Israel
Devices Reimbursement

HSMN NewsFeed - 1 Apr 2014
Cubist Appoints Robert J. Perez to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Mar 2014
Health Canada Approves Biogen Idec's Long-Acting ALPROLIX(TM) Therapy for Hemophilia B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Mar 2014
Portola Pharmaceuticals Appoints John H. Johnson to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Feb 2014
Regulus Appoints Head of Regulus microMarkers(TM) R&D Division
Biopharmaceuticlas Personnel

HSMN NewsFeed - 31 Jan 2014
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Jan 2014
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia
Biopharmaceuticals Licensing

HSMN NewsFeed - 29 Jan 2014
XenoPort Appoints Richard Kim, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 13 Jan 2014
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis
Biopharmaceuticals

HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals

HSMN NewsFeed - 7 Jan 2014
Dr. Seth Rudnick Joins G1 Therapeutics as Executive Chairman
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Jan 2014
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 17 Dec 2013
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in Europe
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2013
FDA Approves Gazyva (Obinutuzumab) for People With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 28 Oct 2013
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Oct 2013
Acorda Therapeutics Appoints Michael Rogers Chief Financial Officer; David Lawrence Named Chief of Business Operations
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 4 Oct 2013
New TECFIDERA(R) (Dimethyl Fumarate) Data Show Sustained Efficacy and Long-Term Safety in a Broad Range of Multiple Sclerosis Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Sep 2013
Biomed Pharmaceuticals Announces Key Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Sep 2013
Amicus Therapeutics Enters Collaboration With Biogen Idec for Parkinson's Disease
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 9 Sep 2013
Biogen Idec and Isis Pharmaceuticals Announce Strategic Collaboration to Advance Treatment of Neurological Disorders
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 6 Sep 2013
Vital Therapies, Inc. Expands Executive Team
Devices Regenerative Medicine Personnel

HSMN NewsFeed - 29 Aug 2013
ObsEva SA Announces CHF 32 Million Series A Funding From Leading Venture Capital Firms and a License Agreement With Merck Serono
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 14 Aug 2013
SAGE Therapeutics Appoints Biotech Industry Veteran Dr. Jeffrey Jonas to Chief Executive Officer; Expands Leadership Team with Two Key Appointments
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 29 Jul 2013
Perrigo Company to Acquire Elan Corporation, plc for US$8.6 Billion, Establishing Premier Global Healthcare Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Jul 2013
Adimab Announces First Antibody Technology Transfer and License Agreement with GlaxoSmithKline
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 Jul 2013
Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2013
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2013
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY(TM) (Peginterferon Beta-1a) in Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2013
Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
Biopharmaceuticals Litigation

HSMN NewsFeed - 18 Apr 2013
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Apr 2013
Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2013
Royalty Pharma Announces Firm Offer to Acquire Elan
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Feb 2013
Biogen Idec to Acquire Full Rights and Control of TYSABRI(R) from Elan for Upfront Cash and Contingent Payments
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 30 Jan 2013
MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 24 Jan 2013
Acorda Therapeutics Announces Department of Defense Contract to Support Study of AC105 in Acute Spinal Cord Injury
Biopharmaceuticals Neurology Neurosurgery

HSMN NewsFeed - 16 Jan 2013
Biogen Idec and Elan Submit Applications for First-Line Use of TYSABRI in Anti-JCV Antibody Negative Patients with MS
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Jan 2013
Biogen Idec Reports Top-Line Results from Phase 3 Trial Investigating Dexpramipexole in People with Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Dec 2012
Acorda Therapeutics Announces Completion of Neuronex, Inc. Acquisition
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Dec 2012
Biogen Executive Kenneth DiPietro Joins InVivo Therapeutics Board of Directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 11 Dec 2012
Galera Therapeutics Raises $11 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 27 Nov 2012
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Oct 2012
New Data from Phase 3 Studies Provide Additional Evidence Supporting Treatment Effect for Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 Oct 2012
Acorda Therapeutics Names Jane Wasman President, International
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2012
Elan Announces the Appointment of Hans Peter Hasler as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2012
Confluence Announces $4 Million in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Aug 2012
Dyax Corp. Creates COO Position and Expands Executive Roles
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Aug 2012
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2012
Cubist Pharmaceuticals Announces Senior Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2012
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 27 Jun 2012
Alnylam Expands and Develops Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2012
EMD Serono, Inc. Strengthens Leadership Teams with New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2012
EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 16 May 2012
Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer
Biopharmaceuticals Personalized Medicine Personnel

HSMN NewsFeed - 23 Apr 2012
Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
Diagnostics Personnel

HSMN NewsFeed - 21 Mar 2012
Seattle Genetics Appoints Dr. Nancy Simonian to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Mar 2012
Alkermes Appoints Mark Stejbach as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Feb 2012
FDA Approves AVONEX(R) PEN(TM) and Dose Titration Regimen
Biopharmaceuticals Drug Delivery Neurology FDA

HSMN NewsFeed - 14 Feb 2012
Biogen Idec to Acquire Stromedix
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Jan 2012
Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jan 2012
Quest Diagnostics STRATIFY JCV(TM) First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
Diagnostics Neurology Personalized Medicine FDA

HSMN NewsFeed - 9 Jan 2012
Gentium Appoints Swedish Orphan Biovitrum AB as Exclusive Distributor of Defibrotide in Nordic and Baltic Territories
Biopharmaceuticals Distribution

HSMN NewsFeed - 10 Oct 2011
Aptus Endosystems Appoints New Board Member
Devices Interventional Personnel

HSMN NewsFeed - 29 Sep 2011
Biogen Idec Promotes Tony Kingsley to Run Global Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2011
Elan Announces Board of Director Changes
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2011
ADVENTRX Announces Appointment of Senior Vice President, Commercial
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2011
Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Jun 2011
Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2011
Biogen Idec Receives Approval in the European Union for AVONEX(R) PEN(TM)
Biopharmaceuticals Drug Delivery Neurology Regulatory

HSMN NewsFeed - 20 May 2011
European Medicines Agency’s Committee for Medicinal Products for Human Use Issues Positive Opinion on Marketing Authorisation Application for FAMPYRA
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 16 May 2011
Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 19 Apr 2011
FDA Approves Rituxan Plus a Steroid for Use in Severe Forms of Vasculitis
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Apr 2011
Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 11 Apr 2011
Biogen Idec Announces Positive Top-Line Results from the First Phase 3 Trial Investigating Oral BG-12 (DIMETHYL FUMARATE) in Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Mar 2011
Gentium Appoints Adrian Haigh as Senior Vice President of Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2011
POZEN Announces Addition to Commercial Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2011
Somaxon Pharmaceuticals Appoints Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jan 2011
ImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 13 Jan 2011
Anders Lundström to Be the New CEO of Orexo
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2011
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2011
Momenta Pharmaceuticals Appoints Young T. Kwon as Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Dec 2010
Swedish Orphan Biovitrum's Long-Lasting Hemophilia A Therapy Receives Orphan Drug Designation in the US
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Dec 2010
Alnylam Elects Marsha Fanucci to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Dec 2010
La Jolla Pharmaceutical Company Announces Appointment of Dr. Bertrand C. Liang to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2010
Elan Names Robert A. Ingram Chairman-Designate
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2010
Faheem Hasnain Named President and Chief Executive Officer of Receptos
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Nov 2010
Vanda Pharmaceuticals Appoints Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2010
Ambit Biosciences Strengthens Board of Directors and Executive Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Sep 2010
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2010
Biogen Idec Makes Statement About U.S. FDA Approval of Gilenya
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Sep 2010
Novartis gains FDA approval for Gilenya, a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 8 Sep 2010
iPierian Announces Second Close of $28 Million Series B Financing
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 18 Aug 2010
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 7 Jul 2010
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jun 2010
Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Jun 2010
Galera Therapeutics Secures Funding for New Cancer Treatment
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 7 Jun 2010
Biogen Idec Provides Update on CEO Search and Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2010
Trubion Pharmaceuticals Wins Genentech and Biogen Idec Patent Appeal
Biopharmaceuticals Litigation

HSMN NewsFeed - 2 Jun 2010
Alnylam Strengthens Management Team with New Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2010
Roche and Biogen Idec Announce Their Decision to Discontinue the ocrelizumab Clinical Development Programme in Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 18 May 2010
Infinity Announces Senior Management Promotion
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2010
Taligen Announces Key Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2010
Taligen Appoints Industry Leader, John Maraganore, as Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2010
Declaratory Relief Complaint for Patent Infringement Under Patent Based on Manufacture, Marketing and Sale of Arzerra
Biopharmaceuticals Oncology Litigation

HSMN NewsFeed - 23 Mar 2010
Rib-X Appoints Mark Leuchtenberger as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Feb 2010
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2010
NeurogesX Announces Management Team Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2010
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Jan 2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jan 2010
Biogen Idec Issues Statement on U.S. Approval of AMPYRA (dalfampridine)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Jan 2010
Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 20 Jan 2010
Constellation Pharmaceuticals Appoints Industry Veteran Garen Bohlin to Senior Management Group
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jan 2010
Med BioGene Appoints World-Renowned Geneticist Dr. Michael R. Hayden as Director
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals

HSMN NewsFeed - 7 Jan 2010
Lycera Appoints Senior Life Sciences Executive William J. Sibold as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2010
Biogen Idec Announces President and Chief Executive Officer James C. Mullen to Retire
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2009
Acceleron Pharma Expands Management Team with Two New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2009
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital

HSMN NewsFeed - 15 Dec 2009
CalciMedica Achieves Milestone and Draws Down Second Tranche of $12 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Dec 2009
Ophthotech Raises $30 Million in Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 11 Dec 2009
Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 10 Dec 2009
William D. Young to Become Chairman of Biogen Idec
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Dec 2009
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Nov 2009
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Nov 2009
Receptos Completes $25M Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Oct 2009
Facet Biotech's Board of Directors Recommends Stockholders Continue to Reject Biogen Idec's Tender Offer
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Oct 2009
CalciMedica Appoints Evelyn Graham to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2009
Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
Biopharmaceuticals Generics

HSMN NewsFeed - 7 Oct 2009
Amber Salzman Named President and CEO of Cardiokine
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2009
Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Sep 2009
AVEO Pharmaceuticals Appoints William J. Slichenmyer, M.D., Sc.M., as Chief Medical Officer and Robert C. Young, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 14 Sep 2009
Elan Cures Breach of Tysabri(R) Collaboration Agreement and Amends Terms of Transaction with Johnson & Johnson
Biopharmaceuticals Litigation

HSMN NewsFeed - 4 Sep 2009
GENova names Dr. John Savin as Vice President
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Jul 2009
Onset Therapeutics Announces Additions to Senior Management Team
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 23 Jul 2009
The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jul 2009
Intellikine Completes $51 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jul 2009
Biogen Idec Receives Fast Track Designation from FDA for PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 1 Jul 2009
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 2 Jun 2009
Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
Diagnostics Distribution

HSMN NewsFeed - 19 May 2009
Celerus Diagnostics Adds International Distribution Expert to Management Team
Diagnostics Personnel

HSMN NewsFeed - 15 May 2009
Avila Therapeutics Appoints Katrine S. Bosley as Company's First CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 May 2009
Archemix Appoints Ken Bate as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2009
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Apr 2009
Eurand Appoints Dr. Robert Becker as Chief Research Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2009
Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2009
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2009
Biogen Idec Names Robert Hamm Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Mar 2009
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
Biopharmaceuticals

HSMN NewsFeed - 9 Feb 2009
MS Patients Treated with TYSABRI Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Jan 2009
Arcxis Biotechnologies(R) Secures Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 21 Jan 2009
Alnylam and Collaborators at Harvard Medical School Demonstrate In Vivo Silencing of Key Genes Implicated in the Transmission of Herpes Simplex Virus-2 (HSV-2)
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2009
Alnylam Provides Update on Kreutzer-Limmer Patent Family
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2009
Hydra Biosciences Raises $22 Million in Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Jan 2009
ARIAD Expands Management Team with Executive Appointments in Regulatory Affairs, Manufacturing and Information Technology
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2008
Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Dec 2008
Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Dec 2008
Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
Devices Cardiology Personnel

HSMN NewsFeed - 1 Dec 2008
FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Nov 2008
Biovitrum's and Syntonix's Novel Factor IXFc for Hemophilia B has Received Orphan Drug Designation From the FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Oct 2008
Tracon Pharmaceuticals Appoints Bryan Leigh, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2008
Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2008
Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2008
Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Sep 2008
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2008
PDL BioPharma Names Faheem Hasnain President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2008
New Long-Term Data Show That Patients Taking AVONEX(R) for up to 15 Years Experience Reduced Disability Progression and Improved Quality of Life
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Sep 2008
Teva Receives EU Marketing Authorization for TevaGrastim(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Sep 2008
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Sep 2008
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Sep 2008
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Aug 2008
Monoclonal Antibody Sales to Almost Double in Coming Years
Biopharmaceuticals

HSMN NewsFeed - 27 Aug 2008
Enrollment Complete in 15-Year Long-Term Follow-Up Study Evaluating Impact of AVONEX(R) in Patients with Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Aug 2008
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Aug 2008
Stromedix Receives Orphan Drug Designation for STX-100 in Chronic Allograft Nephropathy
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Aug 2008
ImmunoGen, Inc. Announces sanofi-aventis Licenses Expanded Access to the Company's TAP Technology
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Aug 2008
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Aug 2008
Regulus Therapeutics Appoints Garry Menzel, Ph.D., as Executive Vice President Corporate Development and Finance
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Jul 2008
ImmunoGen, Inc. Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2008
Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning
Regenerative Medicine Personnel

HSMN NewsFeed - 22 Jul 2008
Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Jul 2008
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jun 2008
Biogen Idec Stockholders Elect Company's Board Nominees
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jun 2008
CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Jun 2008
EyeGate Pharma Appoints Amy Cohen as Vice President, Clinical Operations
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 3 Jun 2008
Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
Biopharmaceuticals

HSMN NewsFeed - 2 Jun 2008
Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles
Biopharmaceuticals Generics

HSMN NewsFeed - 29 May 2008
Biogen Idec Names Hans Peter Hasler Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 May 2008
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 19 May 2008
Biogen Idec Celebrates 30 Years of Transforming Discovery into Care
Biopharmaceuticals

HSMN NewsFeed - 6 May 2008
Apoptos Inc. Raises $28 Million in Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 29 Apr 2008
Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 23 Apr 2008
Ceregene Announces Two Key Additions to Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Apr 2008
Cambria Pharmaceuticals Announces $5.4 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Apr 2008
Biogen Idec Announces Slate of Directors for Annual Meeting of Shareholders
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2008
Biogen Idec and Elan Present New TYSABRI(R) Data at the 60th Annual Meeting of the American Academy of Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Apr 2008
Study Shows that High-Dose, High-Frequency Interferon Produces no Additional Benefit on Efficacy Compared to AVONEX(R) (interferon beta-1a) in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Mar 2008
Micromet Establishes New Scientific Advisory Board for Its BiTE Antibody Technology with Leading Experts in the Fields of Oncology, Immunotherapy and Drug Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2008
Samaritan Pharmaceuticals Acquires Commercialization Rights to Market and Distribute Abiogen's Cancer Drug Abioklad in Greece, Cyprus and Turkey
Biopharmaceuticals Distribution

HSMN NewsFeed - 17 Mar 2008
Zimmer Holdings, Inc. Adds Robert Hagemann and Cecil Pickett to Board of Directors
Devices Personnel

HSMN NewsFeed - 5 Mar 2008
PanGenetics Raises 23 Million Euro in Series C Financing to Fund Clinical Advancement of Its Therapeutic Antibody Programs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Mar 2008
Targanta Strengthens Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Feb 2008
Tercica Announces Changes to Its Board of Directors and Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Feb 2008
TyRx Pharma, Inc. Raises $25 Million in Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Feb 2008
Mylan Announces Appointment of Patrick Vink as Senior Vice President in New Position of Global Head of Biologics
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2008
Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
Regenerative Medicine Personnel

HSMN NewsFeed - 14 Feb 2008
Biogen Idec and Cardiokine Initiate Phase III Clinical Trial for Lixivaptan in Congestive Heart Failure Patients with Hyponatremia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 12 Feb 2008
Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Feb 2008
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2008
Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 4 Feb 2008
Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2008
Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2008
Genentech and Biogen Idec Announce Positive Results from a Phase III Trial of Rituxan in Patients with Rheumatoid Arthritis Who Inadequately Responded to Methotrexate
Biopharmaceuticals

HSMN NewsFeed - 22 Jan 2008
Samaritan Hires Expert Marketing Specialist to Build Up Southeast Europe Sales
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2008
Dr. Manuel Worcel Appointed CEO and President of Cardiokine
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2008
Teva to Acquire CoGenesys
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Jan 2008
Progentix Orthobiology B.V. Closes Series A Financing Round
Regenerative Medicine Venture Capital

HSMN NewsFeed - 14 Jan 2008
FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease
Biopharmaceuticals FDA Gastroenterology

HSMN NewsFeed - 8 Jan 2008
Biogen Idec and PDL BioPharma License the Rights to Develop Volociximab in Ophthalmic Indications to Ophthotech
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 7 Jan 2008
Biogen Idec and Elan Provide Update on Utilization, Safety and Total Patient Exposure of TYSABRI(R) in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Jan 2008
Tempo Pharmaceuticals Closes $8 Million in Series B Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Dec 2007
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 27 Dec 2007
Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 19 Dec 2007
Biogen Idec Announces First Startup in Its Innovation Incubator
Biopharmaceuticals

HSMN NewsFeed - 14 Dec 2007
Alnylam Appoints Barry Greene President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Dec 2007
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Nov 2007
APT Pharmaceuticals Expands Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Nov 2007
Alnylam Expands Management Team with New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2007
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2007
Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Oct 2007
Altus Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Oct 2007
Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
Biopharmaceuticals Regulatory Generics

HSMN NewsFeed - 16 Oct 2007
Metastatix Appoints Carol G. Gallagher, Pharm.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2007
Elan and Biogen Idec Announce That FDA Will Extend Regulatory Review Period for TYSABRI(R) for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 15 Oct 2007
Elan Update
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2007
Biogen Idec and Elan Provide Update on Utilization and Safety of TYSABRI(R) in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 Oct 2007
Optherion, Inc. Completes $37 Million Start Up Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 26 Sep 2007
GlobeImmune Raises $41.2 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Sep 2007
Nephros Raises $12.7 Million in New Financing
Devices Venture Capital

HSMN NewsFeed - 24 Sep 2007
Nodality Names David R. Parkinson, MD as Its CEO
Diagnostics Personnel

HSMN NewsFeed - 24 Sep 2007
Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Sep 2007
Alnylam Announces the Termination of its Collaboration with Merck & Co., Inc.
Biopharmaceuticals

HSMN NewsFeed - 18 Sep 2007
PhotoMedex Hires Paul TanPiengco as Director of Marketing
Devices Personnel

HSMN NewsFeed - 17 Sep 2007
CEO and President David Brand to Leave Cardiokine
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Sep 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Sep 2007
Roche's Tarceva(R) Delivers Longer Life for Lung Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Aug 2007
Vical Names Andrew de Guttadauro Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Aug 2007
TYSABRI(R) Demonstrates Significant Health-Related Quality-of-Life Improvements for Multiple Sclerosis Patients in Study Published in Annals of Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Aug 2007
Cell Therapeutics, Inc. (CTI) Enters Agreement to Acquire Lymphoma Drug Zevalin(R) from Biogen Idec for Sales and Marketing in the United States
Biopharmaceuticals Acquisitions Oncology

HSMN NewsFeed - 14 Aug 2007
Phase II Clinical Trial Results for ADENTRI Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 Aug 2007
Biogen Idec Names Paul J. Clancy Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Aug 2007
Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Diagnostics Oncology

HSMN NewsFeed - 31 Jul 2007
Joint FDA Advisory Committee Recommends Approval of TYSABRI(R) for the Treatment of Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 30 Jul 2007
Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
Biopharmaceuticals Devices Drug Delivery Neurology

HSMN NewsFeed - 24 Jul 2007
Alnylam Expands Management Team with New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2007
TYSABRI(R) Celebrates One-Year Anniversary as a Treatment for Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Jul 2007
Elan and Biogen Idec Preparing to Appeal Ruling on European Application for Natalizumab for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 10 Jul 2007
Cylene Pharmaceuticals Appoints David M. Ryckman, Ph.D. as Vice President of Manufacturing and Pharmaceutical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2007
Roche and Alnylam Form Major Alliance on RNAi Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2007
Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2007
Biogen Idec Announces Management Change
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2007
NUCRYST Pharmaceuticals appoints Katherine J. Turner, PhD to Vice President, Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2007
Alnylam Initiates Phase II Clinical Trial to Evaluate Safety and Anti-viral Efficacy of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus (RSV) Infection
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2007
UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Jun 2007
Experienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on Biologics
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jun 2007
Progen Expands Senior Management Team with Addition of Two Biopharmaceutical Industry Veterans
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Jun 2007
Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Jun 2007
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
NUCRYST Pharmaceuticals appoints Edward Gaj Jr. Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2007
8-Year Long-Term Data Demonstrate Prolonged Overall Survival and Length of Disease Remission With Bexxar(R)
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
Data Show Improved Response Rate When Zevalin Plus Rituximab Follows Short Course First-Line Treatment in Patients with Follicular Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jun 2007
Millennium Appoints Three New Members to Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2007
Peter M. Strumph Named CEO of Nile Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 May 2007
Elan and Biogen Idec Announce a FDA Advisory Committee Meeting to Review TYSABRI(R) for the Treatment of Crohn's Disease
Biopharmacetuicals Gastroenterology FDA

HSMN NewsFeed - 23 May 2007
Tempo Pharmaceuticals Closes $12.1 Million in Series A Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 May 2007
Cougar Biotechnology Announces Additions to Clinical Research and Development Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 May 2007
Tulip BioMed Appoints New President and Chief Operating Officer; Chief Financial Officer Adds Secretary and Treasurer Titles
Devices Personnel

HSMN NewsFeed - 8 May 2007
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 May 2007
Data Presented at the American Academy of Neurology's Annual Meeting Provide Update on Utilization and Safety of TYSABRI(R) in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 May 2007
Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Apr 2007
Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Apr 2007
Dr. Paul A. Foster Joins Reata as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2007
New One-Year Pharmacoeconomic Study Shows AVONEX(R) is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Mar 2007
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Mar 2007
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Mar 2007
ImmunoGen, Inc. Announces Departure of Walter Blattler
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2007
Oncologic Appoints Stephen T. Isaacs as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Feb 2007
Biogen Idec Initiates Randomized, Registrational Trial of Lumiliximab for Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 7 Feb 2007
IRIS Submits 510(k) Application To FDA For Its N.A.D.I.A. Prostate Cancer Test
Diagnostics Oncology FDA

HSMN NewsFeed - 25 Jan 2007
Biogen Idec Initiates Phase III Trial of Galiximab for Follicular Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Jan 2007
Kenneth M. Bate Named CEO of NitroMed
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2007
Proteolix Elects Dr. Michael Kauffman Chairman of the Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Jan 2007
Biogen Idec Initiates Phase III Clinical Program of Oral Compound BG-12 for Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Jan 2007
Alnylam Announces Key Product and Business Goals for 2007
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2007
Biogen Idec to Acquire Syntonix
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Jan 2007
NovaCardia Appoints John E. Crawford as Chief Financial Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 29 Dec 2006
Ventana Medical Systems Announces Court of Appeal Decision
Diagnostics Litigation

HSMN NewsFeed - 26 Dec 2006
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an Option Agreement for Expanded Access to the Company's TAP Technology
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 15 Dec 2006
Elan and Biogen Idec Submit Supplemental Biologics License Application to the FDA for the Approval of TYSABRI(R) as a Treatment for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 12 Dec 2006
Interim Analysis of Phase III Trial Shows Avastin Plus Interferon Therapy Improved Progression-Free Survival in Patients With Previously Untreated Advanced Renal Cell Carcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Dec 2006
Intranasal Therapeutics, Inc. Adds Key Executives to Management Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 5 Dec 2006
Alnylam Advances a Systemically Delivered RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia as New Development Program
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2006
Alnylam Initiates Clinical Program to Evaluate Anti-Viral Activity for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
Biopharmaceuticals

HSMN NewsFeed - 21 Nov 2006
Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Nov 2006
Anadys Pharmaceuticals Names Lawrence C. Fritz, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Nov 2006
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Oct 2006
Kosan Appoints Robert De Jager as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Oct 2006
TYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 20 Oct 2006
AVONEX(R), The #1 Prescribed Multiple Sclerosis Therapy Worldwide, Improves Patient Convenience
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 19 Oct 2006
New Landmark Study Shows the Use of a BiovaxID Formulation Improves Disease Free survival in 80% of Patients Whose Cancer has Relapsed after Chemotherapy Administered With or Without Rituxan
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Oct 2006
FDA Approves Avastin(R) in Combination With Chemotherapy for First-Line Treatment of Most Common Type of Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Oct 2006
RHEI Pharmaceuticals Appoints Timothy M. Kish President and CFO
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Oct 2006
New Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 4 Oct 2006
Schering AG and Biogen Idec Announce Start of the ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin(R)
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Oct 2006
Amicus Therapeutics Appoints Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Sep 2006
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 Sep 2006
Alnylam Announces Management Transition Plan in Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Sep 2006
AVONEX(R), the #1 Prescribed Multiple Sclerosis (MS) Therapy Worldwide: New MRI Data Presented
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Sep 2006
New Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Sep 2006
New Data on TYSABRI(R) Presented at ECTRIMS Congress Demonstrate Significant Improvement in Cognitive Function in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Sep 2006
New Study: AVONEX(R), The Most Prescribed Multiple Sclerosis Treatment Worldwide, Demonstrates Superior Adherence
Biopharmaceuticals Neurology

HSMN NewsFeed - 22 Sep 2006
Neose Provides Update on GlycoPEG-GCSF Program
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Sep 2006
Biogen Idec and Alnylam Form Alliance to Discover and Develop Therapeutics for the Potential Treatment of Progressive Multifocal Leukoencephalopathy (PML)
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Sep 2006
Targanta Appoints Mark Leuchtenberger, Former President and CEO of Therion Biologics Corporation, as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Sep 2006
Biogen Idec and mondoBIOTECH Sign Collaboration and Licensing Agreement to Develop and Commercialize Aviptadil for Pulmonary Arterial Hypertension
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Sep 2006
ADVENTRX Announces Senior Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Sep 2006
BioGenex Names Medical Technology Executive Raymond W. Cohen to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 24 Jul 2006
Biogen Idec and Elan Announce Availability of TYSABRI(R) for the Treatment of Relapsing Forms of Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Jul 2006
Poniard Pharmaceuticals Appoints Alan B. Glassberg, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2006
Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of Menstrual Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jul 2006
Dr. Harold Handley Appointed President of Aethlon Medical, Inc.
Devices Personnel

HSMN NewsFeed - 12 Jul 2006
Biogen Idec Names Cecil B. Pickett President, Research & Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jul 2006
Schering-Plough Announces Executive Changes in Schering-Plough Research Institute
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2006
ImmunoGen, Inc. Grants Biotest AG Rights to Use ImmunoGen TAP Technology to Develop Novel Anticancer Therapeutics
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Jul 2006
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2006
OXiGENE'S Board of Directors Names Experienced Biotech Executive, Richard Chin, M.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2006
TYSABRI(R) Receives Approval in European Union for the Treatment of Relapsing Remitting Forms of Multiple Sclerosis
Biopharmaceuticals Regulatory Neurology

HSMN NewsFeed - 27 Jun 2006
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Jun 2006
Analysis of Phase III Study Showed Rituxan(R) Plus Methotrexate Reduced Joint Damage in Rheumatoid Arthritis Patients Who Respond Inadequately to TNF Antagonist Therapies
Biopharmaceuticals

HSMN NewsFeed - 31 May 2006
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2006
Biogen Idec to Acquire Fumapharm AG
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 May 2006
Oral Compound BG-12 Achieves Primary Endpoint in Phase II Study of Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 May 2006
Genentech Submits Supplemental Biologics License Application for Avastin With Chemotherapy in First-Line Metastatic Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 23 May 2006
Clera Announces Senior Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2006
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 May 2006
AVONEX(R), the Most Prescribed Multiple Sclerosis Therapy Worldwide, Celebrates 10th Anniversary
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 May 2006
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 May 2006
MorphoSys and Schering-Plough Sign R&D Agreement
Biopharmaceuticals

HSMN NewsFeed - 15 May 2006
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2006
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Biopharmaceuticals

HSMN NewsFeed - 4 May 2006
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
Biopharmaceuticals

Return to NewsFeed

Additional items found! 318

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 318 additional stories matching:
Biogen
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.